Insider Transactions in Q3 2025 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-4.06%
|
$3,950
$1.36 P/Share
|
|
Sep 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+11.38%
|
-
|
|
Sep 10
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-2.78%
|
$9,664
$1.36 P/Share
|
|
Sep 10
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,083
+7.22%
|
-
|
|
Sep 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,348
-2.73%
|
$10,348
$1.36 P/Share
|
|
Sep 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,000
+7.1%
|
-
|